BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
203 results:

  • 1. Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages.
    Xu L; Chen Y; Liu L; Hu X; He C; Zhou Y; Ding X; Luo M; Yan J; Liu Q; Li H; Lai D; Zou Z
    PLoS Genet; 2024 Apr; 20(4):e1011235. PubMed ID: 38648200
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The endonuclease FEN1 mediates activation of stat3 and facilitates proliferation and metastasis in breast cancer.
    Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
    Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PDP1 promotes the progression of breast cancer through stat3 pathway.
    Wang Y; Dang H; Qiao H; Tian Y; Guan Q
    Cell Biochem Funct; 2024 Apr; 42(3):e3994. PubMed ID: 38566355
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer.
    Haq ATA; Yang PP; Jin C; Shih JH; Chen LM; Tseng HY; Chen YA; Weng YS; Wang LH; Snyder MP; Hsu HL
    Theranostics; 2024; 14(5):2167-2189. PubMed ID: 38505617
    [No Abstract]    [Full Text] [Related]  

  • 5. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma.
    Duan Y; Zhou M; Ye B; Yue K; Qiao F; Wang Y; Lai Q; Wu Y; Cao J; Wu Y; Wang X; Jing C
    Cell Death Dis; 2024 Mar; 15(3):215. PubMed ID: 38485986
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.
    Wang X; Deng X; Hu J; Zheng W; Ye D; Zhou X; Fang L
    Cancer Lett; 2024 Apr; 588():216764. PubMed ID: 38431034
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
    Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
    Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.
    Effat H; Abosharaf HA; Radwan AM
    Sci Rep; 2024 Feb; 14(1):2824. PubMed ID: 38310190
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
    Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
    Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The APE1/REF-1 and the hallmarks of cancer.
    Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
    Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. In Vitro and In Vivo Anti-cancer Activity of Lasiokaurin in a Triple-Negative breast cancer Model.
    Lin J; Qu Z; Pu H; Shen LS; Yi X; Lin YS; Gong RH; Chen GQ; Chen S
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067432
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.
    Streitfeld WS; Dalton AC; Howley BV; Howe PH
    Cancer Biol Ther; 2023 Dec; 24(1):2271638. PubMed ID: 37927213
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive breast cancer: A comprehensive Literature Review.
    Yu Q; Xu C; Song J; Jin Y; Gao X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117322. PubMed ID: 37866466
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model.
    Wan H; Yang X; Sang G; Ruan Z; Ling Z; Zhang M; Liu C; Hu X; Guo T; He J; Liu D; Pei J
    Aging (Albany NY); 2023 Oct; 15(20):11244-11267. PubMed ID: 37857018
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative breast cancer Cells by Promoting Apoptosis and Inhibiting the stat3/EMT Axis.
    Park SJ; Jung HJ
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
    Mei M; Tang L; Zhou H; Xue N; Li M
    Eur J Pharmacol; 2023 Nov; 959():176076. PubMed ID: 37797675
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Effect of Metformin on Triple-Negative breast cancer Cells and Nude Mice.
    Song J; Du J; Han L; Lin X; Fan C; Chen G
    Altern Ther Health Med; 2023 Nov; 29(8):389-395. PubMed ID: 37632970
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating stat3-Induced Expression of PD-L1 in Multiple cancers.
    Xiao D; Zeng T; Zhu W; Yu ZZ; Huang W; Yi H; Lu SS; Feng J; Feng XP; Wu D; Wen Q; Zhou JH; Yuan L; Zhuang W; Xiao ZQ
    Cancer Immunol Res; 2023 Oct; 11(10):1367-1383. PubMed ID: 37566399
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review).
    Zheng L; Chen X; Zhang L; Qin N; An J; Zhu J; Jin H; Tuo B
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539774
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.